Get the Stockscreener App
1.52
2.56%
-0.04
After Hours:
1.49
-0.03
-1.97%
22nd Century Group, Inc. stock is traded at $1.52, with a volume of 701.32K.
It is down -2.56% in the last 24 hours and down -10.06% over the past month.
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
See More
Previous Close:
$1.56
Open:
$1.57
24h Volume:
701.32K
Relative Volume:
0.40
Market Cap:
$5.75M
Revenue:
$29.78M
Net Income/Loss:
$-39.94M
P/E Ratio:
-0.0246
EPS:
-61.9139
Net Cash Flow:
$-16.12M
1W Performance:
-9.52%
1M Performance:
-10.06%
6M Performance:
+59.51%
1Y Performance:
-93.22%
1-Day Range:
$1.46
$1.5837
1-Week Range:
$1.46
$1.6944
52-Week Range:
$0.432
$22.94
22nd Century Group, Inc. Stock (XXII) Company Profile
Name
22nd Century Group, Inc.
Sector
Industry
Phone
716-270-1523
Address
8560 Main Street, Williamsville, NY
Compare XXII with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
1.52 | 5.90M | 29.78M | -39.94M | -16.12M | -61.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-22 | Initiated | Alliance Global Partners | Buy |
| Jun-15-22 | Initiated | Craig Hallum | Buy |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Jul-23-21 | Initiated | Cowen | Outperform |
| Oct-16-17 | Reiterated | Chardan Capital Markets | Buy |
| Aug-11-16 | Reiterated | Chardan Capital Markets | Buy |
View All
22nd Century Group, Inc. Stock (XXII) Latest News
Can volume confirm reversal in 22nd Century Group Inc.Rate Hike & Community Verified Trade Signals - newser.com
Chart based analysis of 22nd Century Group Inc. trendsJuly 2025 Trends & Technical Analysis for Trade Confirmation - newser.com
Visual trend scoring systems applied to 22nd Century Group Inc.2025 Analyst Calls & Weekly Top Gainers Alerts - newser.com
What Fibonacci levels say about 22nd Century Group Inc. reboundJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com
Reversal indicators forming on 22nd Century Group Inc. stockDividend Hike & Stepwise Swing Trade Plans - newser.com
Technical analysis overview for 22nd Century Group Inc. stockEarnings Recap Summary & Proven Capital Preservation Methods - newser.com
Published on: 2025-10-09 05:06:40 - newser.com
22nd Century shares rise as company announces debt-free balance sheet and new growth capital - MSN
Is 22nd Century Group Inc a good long term investmentRisk Management Strategies & Exceptional Profit Growth - earlytimes.in
Is this a good reentry point in 22nd Century Group Inc.Market Performance Report & Precise Buy Zone Tips - newser.com
Can you recover from losses in 22nd Century Group Inc.Jobs Report & Growth Oriented Trading Recommendations - newser.com
Pattern recognition hints at 22nd Century Group Inc. upsideJuly 2025 Trade Ideas & Daily Technical Forecast Reports - newser.com
Identifying reversal signals in 22nd Century Group Inc.Portfolio Update Report & Growth Oriented Trading Recommendations - newser.com
22nd Century Group Backs FDA’s Proposed Reduced Nicotine Standard - Tobacco Reporter
22nd Century Group backs FDA’s proposed nicotine reduction standard By Investing.com - Investing.com Australia
22nd Century Group backs FDA’s proposed nicotine reduction standard - Investing.com India
22nd Century Submits Comments to FDA in Support of Proposed Reduced Nicotine Content Mandate - The Manila Times
$600 Billion Annual Health Impact: 22nd Century Backs FDA Plan to Slash Nicotine in All US Cigarettes - Stock Titan
22nd Century Group Hits New 52-Week Low at $1.56 Amidst Declining Sales - Markets Mojo
22nd Century Settles $9.5M Insurance Claim, Eyes 2026 Profitability - Tobacco Reporter
XXII Shows Promise: Is It Time to Buy? - timothysykes.com
Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket - Benzinga
22nd Century Settles Insurance Litigation for $9.5M - TipRanks
22nd Century Group Stock Rockets 30% Premarket On Scoring $9.5M Insurance Payday, Retail Traders Pile In - Stocktwits
22nd Century Group settles insurance claim for $9.5 million By Investing.com - Investing.com Nigeria
What does recent volatility data suggest for 22nd Century Group Inc.Earnings Growth Report & Stepwise Swing Trade Plans - newser.com
22nd Century Group settles insurance claim for $9.5 million - Investing.com
22nd Century (XXII) Finalizes $9.5M Settlement for Grass Valley Incident - GuruFocus
22nd Century Group stock soars after $9.5 million insurance settlement By Investing.com - Investing.com Nigeria
22nd Century Group stock soars after $9.5 million insurance settlement - Investing.com
22nd Century Group, Inc. Stock (XXII) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):